-15% New

Bromantane 25 mg – 60 capsules

Name: Bromantane 25 mg – 60 capsules
Brand: Peptide Revolution
SKU: PR-044
Price: 55.24 EUR
Availability: BackOrder
Rating: 5 (1 reviews)

Original price was: 64,99 €.Current price is: 55,24 €.

Find out what benefits peptides have

Discover how peptides can boost recovery, improve skin health, increase energy and support overall performance. Explained simply and clearly in this short video.

Product Description

Research Compound · Capsules

Bromantane 25 mg – 60 Capsules

Research-grade compound supplied as 60 pre-portioned capsules, each containing 25 mg bromantane (Ladasten). An adamantane-derivative compound studied in controlled experimental models of dopaminergic transmission, neuroplasticity and synaptogenesis, stress/fatigue response pathways, and mitochondrial bioenergetics.

Research Use Only

This product is intended strictly for laboratory and scientific investigation. Not for human consumption, therapeutic use, or veterinary application.

Specifications

Purity

≥99% (HPLC, third-party tested, CoA on file)

Form

Research capsules

Content per Capsule

25 mg bromantane

Total per Bottle

60 capsules (1.5 g total)

Packaging

Sealed bottle with tamper-evident closure

Storage

Store at room temperature, dry, protected from light

Molecular Formula

C₁₆H₂₀BrN

Molecular Weight

≈ 306.25 g/mol

IUPAC Name

N-(4-bromophenyl)adamantan-2-amine

CAS Number

87913-26-6

Format

Supplied as pre-portioned research capsules — no reconstitution or weighing is required, supporting consistent dosing accuracy in controlled experimental workflows. Keep the bottle sealed and stored at room temperature, dry and protected from light.

Research Overview

Bromantane (Ladasten) is an adamantane-derivative compound developed in Russia in the 1980s. Mechanistically, it is distinguished from classical psychostimulants by acting on dopamine biosynthesis rather than monoamine release — upregulating tyrosine hydroxylase and aromatic L-amino acid decarboxylase expression while modulating dopamine transporter activity. It is characterised in the literature as an actoprotector, and in controlled experimental settings it is used as a tool compound in dopaminergic signaling, neuroplasticity and stress/fatigue-response research. No therapeutic or clinical claims are made or implied.